sulfasalazine has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Squamous Cell Carcinoma of Head and Neck: The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okazaki, S | 1 |
| Umene, K | 1 |
| Yamasaki, J | 1 |
| Suina, K | 1 |
| Otsuki, Y | 1 |
| Yoshikawa, M | 1 |
| Minami, Y | 1 |
| Masuko, T | 1 |
| Kawaguchi, S | 1 |
| Nakayama, H | 1 |
| Banno, K | 1 |
| Aoki, D | 1 |
| Saya, H | 1 |
| Nagano, O | 1 |
1 other study available for sulfasalazine and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma.
Topics: Amino Acid Transport System ASC; Amino Acid Transport System y+; Animals; Anti-Inflammatory Agents, | 2019 |